Intervention

Dimethyl Fumarate Enteric-coated Capsules

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting2

Common conditions3

Lead sponsors shown2

Clinical trials

3 shown

Open-Label Study of Dimethyl Fumarate in Adults With Type 1 DiabetesNCT07548996 · 2026-04-27

Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes MellitusNCT07258394 · 2026-01-27

A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)NCT07138833 · 2025-09-01

NOT_YET_RECRUITING

Common conditions

Relapsing Multiple Sclerosis1 Type 1 Diabetes1 Type 1 Diabetes Mellitus1

Leading sponsors

Nanjing Medical University2 Qilu Pharmaceutical (Hainan) Co., Ltd.1

Trial status mix

RECRUITING2

NOT_YET_RECRUITING1

Phase mix

PHASE32

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.